Highly-sensitive troponin I is increased in patients with gynecological cancers

OBJECTIVES: To investigate troponin I (TnI) in patients with gynecological cancers. METHODS: Highly-sensitive (HS) and conventional TnI were measured in 25 patients with untreated ovarian cancer, 25 with endometriosis and 25 with benign masses. RESULTS: Both HS and conventional TnI were increase in cancer patients. Values above the cut-off were found in 44% and 16% cancer patients using HS and conventional TnI methods, respectively. CONCLUSIONS: Cardiac involvement is frequent in patients with gynecological cancers and should be preferably assessed using HS troponin immunoassays.